DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

MannKind Corp

NASDAQ: MNKD

5.19 0.03 (0.58%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $5.19 0.58%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.18
Previous Close $5.16
Daily Range $5.12 - $5.45
52-Week Range $1.57 - $5.45
Market Cap $1.5B
P/E Ratio -6.29
Dividend (Yield) $0.00 (0.0%)
Volume 10,208,696
Average Daily Volume 5,339,986
Current FY EPS -$0.47

Sector

Healthcare

Industry

Drugs

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary

1 Giant Leap for MannKind

MannKind shares have jumped over the moon lately. What's behind this giant leap?

Why MannKind's Afrezza Will Succeed Where Pfizer Failed

Benzinga's Top Initiations

Narrower-than-Expected Loss at MannKind - Analyst Blog

5 of Last Week's Biggest Winners

These five stocks posted double-digit gains this past week.

3 Investment Strategy Lessons From Vertex's Success

Can you develop an investment strategy based on a biotech success story? Here are 3 lessons that show how it can be done.

MannKind's Countdown to Liftoff?

Is MannKind on a countdown to liftoff, or will there be a failure to launch? Some clues came in the biotech's latest quarterly results.

MannKind Corporation's CEO Discusses Q1 2013 Results - Earnings Call Transcript

MannKind Corporation Reports 2013 First Quarter Financial Results

MannKind to Present at Bank of America Merrill Lynch 2013 Health Care Conference

See More MNKD News...

MNKD's Top Competitors

MNKD $5.19 (0.58%)
Current stock: MNKD
AMGN $105.63 (0.63%)
Current stock: AMGN
GILD $56.30 (2.44%)
Current stock: GILD
BIIB $226.85 (-0.50%)
Current stock: BIIB